In line with these results, we confirmed the enrichment of ILC2s in a large cohort of patients with PCa in a Gleason score-dependent manner and demonstrated that ILC2s were hyperactivated, producing high levels of IL-13 and IL-5. The gene discussed is IL13; the disease is posterior cortical atrophy.